Improving Motorcycle Taxi Driver Visibility in Tanzania

August 6, 2013 updated by: Duke University

Improving Motorcycle Taxi Driver Visibility in Tanzania-A Cluster Randomized Controlled Trial

The purpose of this study is to determine whether providing motorcycle taxi drivers with a free reflective fluorescent vest will result in increased use of reflective or fluorescent clothing compared to education about wearing reflective or fluorescent clothing alone.

Study Overview

Detailed Description

Road traffic injuries are the 4th leading cause of death among individuals in the economically productive age group (age 15 to 59) in low and middle income countries. The Africa region currently has some of the world's highest traffic injury rates, with vulnerable road users, including motorcycle riders, bearing a disproportionate share of the injury burden.

Motorcycles are a rapidly growing form of transport in Africa, both for personal and commercial transportation. Conspicuity measures-factors that increase a motorcycle rider's visibility-for the prevention of motorcycle crash have been previously studied and found to be associated with a decreased risk of crash.

Motorcycle taxi drivers are a particularly high risk population for motorcycle crash as they operate a motorcycle for several hours a day. Reflective, fluorescent safety vests are a common article worn by motorcycle drivers in some locations; however, penetration of such clothing in Moshi is currently low. This study aims to increase use of reflective vests among commercial motorcycle drivers. We will test whether provision of a free reflective, fluorescent vest increases use of reflective, fluorescent clothing compared to education about wearing reflective, fluorescent clothing alone.

Study Type

Interventional

Enrollment (Actual)

180

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Kilimanjaro Region, Tanzania
        • Kilimanjaro region, Tanzania

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • motorcycle riders who identify themselves as motorcycle taxi drivers
  • individuals must work at least 2 days a week as a motorcycle taxi driver
  • have a telephone number for ride solicitation
  • have a license plate that is able to be recorded
  • are at least 18 years old
  • are willing to have us contact them in the future for repeat surveys

Exclusion Criteria:

  • motorcycle riders who do not meet the above criteria
  • motorcycle riders who do not consent to participate

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Vest and Education
Motorcycle Taxi Drivers provided with a reflective, fluorescent vest and basic education about recommended measures to increase their visibility
Motorcycle taxi drivers in the intervention arm will receive a free reflective, fluorescent vest
Both arms will receive brief, basic education about recommended measures to increase their visibility
Other: Education Alone
Motorcycle Taxi Drivers provided with basic education about recommended measures to increase their visibility
Both arms will receive brief, basic education about recommended measures to increase their visibility

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Use of reflective or fluorescent clothing
Time Frame: 3-5 months
The use of reflective or fluorescent clothing will be compared between the intervention and control groups over the observation period
3-5 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Wearing White Helmet
Time Frame: 3-5 months
The use of white helmets will be compared between the intervention and control groups over the observation period
3-5 months
Daytime Running Headlights
Time Frame: 3-5 months
The use of daytime running headlights will be compared between the intervention and control groups over the observation period
3-5 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Nathan M Thielman, MD, MPH, Duke University
  • Study Director: Steven A Sumner, MD, Duke University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2013

Primary Completion (Actual)

June 1, 2013

Study Completion (Actual)

June 1, 2013

Study Registration Dates

First Submitted

November 21, 2012

First Submitted That Met QC Criteria

November 21, 2012

First Posted (Estimate)

November 27, 2012

Study Record Updates

Last Update Posted (Estimate)

August 9, 2013

Last Update Submitted That Met QC Criteria

August 6, 2013

Last Verified

August 1, 2013

More Information

Terms related to this study

Other Study ID Numbers

  • Pro00034415
  • 1R25TW009337-01 (U.S. NIH Grant/Contract)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Accidents, Traffic

Subscribe